Laurus Labs Monthly Outlook (March 2026) | Price, Target Price & Growth

Laurus Labs

NSEI:LAURUSLABS

Rp 1.023,50

Rp0,00 (0,00%)

1.023,50 Rp

Rp0,00 (0,00%)

End-of-day quote: 03/27/2026

Laurus Labs Stock Value

Currently, analysts rate NSEI:LAURUSLABS as Hold.

Hold

Laurus Labs Company Info

EPS Growth 5Y

6,75%

Market Cap

Rp552,54 B

Long-Term Debt

Rp6,46 B

Annual earnings

04/24/2026

Dividend

Rp1,64

Dividend Yield

0,16%

Founded

2005

Industry

Health Care

Country

India

Website

Laurus Labs

ISIN Number

INE947Q01028

Website

http://www.lauruslabs.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp1.007,50

-1.56%

Last Update: 03/28/2026

Analysts: 14

Highest Price Target Rp1.280,00

Average Price Target Rp1.007,50

Lowest Price Target Rp510,00

In the last five quarters, Laurus Labs’s Price Target has risen from Rp151,32 to Rp370,83 - a 145,06% increase. Twelve analysts predict that Laurus Labs’s share price will fall in the coming year, reaching Rp1.007,50. This would represent a decrease of -1,56%.

Top growth stocks in the health care sector (5Y.)

What does Laurus Labs do?

Laurus Labs Limited a pharmaceutical and biotechnology company, which develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations. Products and Services Active Pharmaceutical Ingredients (APIs) The company specializes in the development and manufacture of APIs, which are the essential components of pharmaceutical drugs. The company’s API portfolio includes products used in the treatment of antiretroviral (ARV), oncology, cardiovascular, anti-dia...

Laurus Labs Limited a pharmaceutical and biotechnology company, which develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations.

Products and Services

Active Pharmaceutical Ingredients (APIs)

The company specializes in the development and manufacture of APIs, which are the essential components of pharmaceutical drugs. The company’s API portfolio includes products used in the treatment of antiretroviral (ARV), oncology, cardiovascular, anti-diabetic, anti-asthmatic, and gastroenterology therapeutic segments. The company’s APIs are developed and manufactured in-house, ensuring high quality and compliance with international regulatory standards.

Formulations

The company’s formulations business involves the development and manufacture of finished dosage forms (FDFs). The company’s formulations are used in various therapeutic areas, including ARV, oncology, cardiovascular, anti-diabetic, anti-asthmatic, and gastroenterology. The company’s formulations are developed using its in-house API expertise, ensuring a seamless integration of its product offerings.

Custom Synthesis and Contract Manufacturing

The company offers custom synthesis and contract manufacturing services to pharmaceutical and biotechnology companies. The company’s expertise in chemical synthesis, process development, and manufacturing enables it to provide high-quality and cost-effective solutions to its clients. The company’s custom synthesis and contract manufacturing services include the development and manufacture of APIs, intermediates, and formulations.

Biotechnology

The company is involved in the development and manufacture of biotechnology products. The company’s biotechnology portfolio includes products used in the treatment of various therapeutic areas, including oncology, cardiovascular, anti-diabetic, anti-asthmatic, and gastroenterology. The biotechnology products are developed using advanced technology and adhere to stringent regulatory standards.

Research and Development

The company places significant emphasis on research and development (R&D) to drive innovation and maintain its competitive edge. The company’s R&D activities are focused on the development of new APIs, formulations, and biotechnology products. The R&D team comprises experienced scientists and researchers who work on cutting-edge technologies and processes.

Geographical Markets

The company serves a broad range of geographical markets in India and internationally.

Customers

The company serves a diverse range of customers in the pharmaceutical and biotechnology sectors. The company’s customer base includes various categories, such as pharmaceutical companies, biotechnology firms, and healthcare organizations.

Government Regulations

The company is subject to a range of government regulations that oversee its pharmaceutical and biotechnology operations. These regulations are designed to ensure the safety, efficacy, and quality of the company’s products, as well as to protect public health and the environment. Key government regulations applicable to the company include:

Drugs (Control) Act, 1950: This act regulates the production, distribution, and pricing of essential drugs in India. It ensures the availability of essential medicines at reasonable prices.

Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945: These regulations govern the import, manufacture, distribution, and sale of drugs and cosmetics in India. The company complies with these regulations to ensure the safety and quality of its products.

Narcotic Drugs and Psychotropic Substances Act, 1985: This act regulates the manufacture, possession, sale, and distribution of narcotic drugs and psychotropic substances. The company adheres to this regulation to prevent the misuse of controlled substances.

The Food Safety and Standards Act, 2006: This act establishes standards for the manufacture, storage, distribution, sale, and import of food products to ensure their safety and quality. The company complies with this act for any products that fall under its purview.

The Indian Boilers Act, 1923: This act regulates the design, construction, operation, and maintenance of boilers in India. The company ensures compliance with this act to maintain the safety and efficiency of its boiler operations.

In addition, the company adheres to various industry-specific regulations and guidelines prescribed by regulatory authorities, such as the Securities and Exchange Board of India (SEBI). Key industry regulations applicable to the company include:

The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011: These regulations govern the acquisition of shares and takeovers of listed companies in India. The company complies with these regulations to ensure transparency and fairness in its share acquisition activities.

The Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015: These regulations prohibit insider trading and ensure that all investors have equal access to material information. The company adheres to these regulations to maintain market integrity.

The Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018: These regulations govern the issuance of securities and the disclosure requirements for listed companies. The company complies with these regulations to ensure transparency and protect investor interests.

The Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021: These regulations govern the issuance of share-based employee benefits and sweat equity shares. The company adheres to these regulations to ensure fair and transparent employee compensation practices.

The Securities and Exchange Board of India (Registrars to an Issue and Share Transfer Agents) Regulations, 2018: These regulations govern the activities of registrars and share transfer agents. The company complies with these regulations to ensure efficient and transparent share transfer processes.

Environmental Laws

The company is committed to environmental sustainability and adheres to various environmental laws and regulations to minimize its environmental impact. Key environmental laws applicable to the company include:

Water (Prevention and Control of Pollution) Act: This act regulates the prevention and control of water pollution in India. The company ensures compliance with this act to maintain the quality of water resources and prevent water pollution.

Air (Prevention and Control of Pollution) Act: This act regulates the prevention and control of air pollution in India. The company adheres to this act to maintain air quality and reduce air pollution from its operations.

Environment Protection Act and Rules Thereunder: This act provides the framework for the protection and improvement of the environment in India. The company complies with this act and its associated rules to ensure the sustainability of its operations and minimize its environmental impact.

History

Laurus Labs Limited was founded in 2005. The company was incorporated in 2005.

Laurus Labs Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical active ingredients (APIs):** approx. 50% **Formulations:** approx. 30% **Synthetic biology and others:** approx. 20% **TOP 3 Markets:** 1. **India:** approx. 40% 2. **USA:** approx. 30% 3. **Europe:** approx. 15% Laurus Labs Limited generates the majority of its revenues from...

At which locations are the company’s products manufactured?

**Production Sites:** Hyderabad, Visakhapatnam (as of 2023) Laurus Labs Limited mainly produces its products in India. The key production facilities are located in Hyderabad and Visakhapatnam. These sites are strategically chosen to maximize efficiency in the manufacturing of pharmaceutical product...

What strategy does Laurus Labs pursue for future growth?

**Revenue Growth:** Estimated 10-12% annually (based on historical data and market trends until 2023) **Focus on Research and Development:** Laurus Labs has significantly invested in R&D in recent years to expand its product pipeline and develop innovative pharmaceutical solutions. **Expansion...

Which raw materials are imported and from which countries?

**Main raw materials:** Active Pharmaceutical Ingredients (APIs), intermediates **Countries of origin:** China, USA, Europe Laurus Labs Limited mainly imports Active Pharmaceutical Ingredients (APIs) and intermediates that are needed for the production of their pharmaceutical products. A significa...

How strong is the company’s competitive advantage?

**Market share in API production:** 8% (estimated 2024) **R&D expenses:** 5.2% of revenue (2024) **EBITDA margin:** 21% (2024) Laurus Labs Limited has established itself as a significant player in the pharmaceutical industry, particularly in the active pharmaceutical ingredients (APIs) sect...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** approximately 30% (estimated, 2025) **Insider Buys/Sells:** No significant transactions reported (2025) The institutional investor share in Laurus Labs Limited is estimated to be around 30%. This number can vary depending on market conditions and fund investment s...

What percentage market share does Laurus Labs have?

**Market share of Laurus Labs Limited:** Estimated around 5% (2025) **Top competitors and their market shares:** 1. **Sun Pharmaceutical Industries Ltd:** around 20% 2. **Dr. Reddy's Laboratories Ltd:** around 15% 3. **Cipla Ltd:** around 12% 4. **Aurobindo Pharma Ltd:** around 10% 5. **Lupin...

Is Laurus Labs stock currently a good investment?

**Revenue Growth:** 18% (2024) **Profit Growth:** 14% (2024) **Research and Development Ratio:** 7% of revenue (2024) Laurus Labs Limited achieved solid revenue growth of 18% in 2024, indicating strong demand for its pharmaceutical products and services. The 14% profit growth during the same period...

Does Laurus Labs pay a dividend – and how reliable is the payout?

**Dividend Yield:** 1.8% (estimated for 2025) **Dividend History:** Regular payouts over the past 5 years Laurus Labs Limited has paid dividends in recent years, with the dividend yield estimated to be around 1.8% for 2025. The company has regularly distributed dividends over the past five years,...

New support ticket

Explore

Laurus Labs Stock Value

Laurus Labs Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Laurus Labs do?

Laurus Labs Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Laurus Labs Stock Value

Laurus Labs Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Laurus Labs do?

Laurus Labs Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.